Newly prescribed Benzodiazepine or Antipsychotic Use tied to Higher Mortality in Dementia Patients: JAMA
A case-control study of Medicare data has found that older adults with Alzheimer’s disease or other forms of dementia who were newly prescribed benzodiazepines or antipsychotics in hospice care had higher mortality compared with those not receiving these medications. The study, published in JAMA Network Open by Wang L. and colleagues, analyzed prescribing patterns and outcomes in a large population of hospice patients. Researchers noted that these medications were typically initiated about three days after hospice enrollment, with patients having an average hospice stay of over 135 days. The findings underscore the potential risks associated with psychotropic medication use in vulnerable populations with advanced cognitive decline.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!